new oversight of pharmacy compounding

December 2012

The fungal meningitis outbreak will result in new oversight of pharmacy compounding.

We all know that compounding fills several important needs. Up to 3% of all prescriptions are compounded.

But it gets confusing when a compounder acts like a manufacturer.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Vaccines more focus on proper vaccine storage
Antidepressants The new Forfivo XL (for-FIVE-oh, bupropion) will increase the chance of mix-ups among bupropion forms
Rheumatoid Arthritis Rayos, a new delayed-release prednisone
Interactions drug interaction alerts between methotrexate and "PPI" stomach acid reducers (omeprazole, pantoprazole, etc)
Gastroenterology the new drug, Linzess (lin-ZESS, linaclotide)
Side Effects more about bleeding with Pradaxa (dabigatran) and Xarelto (rivaroxaban)
Beta-Blockers changes in prescriptions for "beta-blockers" (propranolol, metoprolol, etc) being used for heart disease
Inhalers Tudorza Pressair (TU-door-za, aclidinium), for chronic obstructive pulmonary disease (COPD)
Diabetes debate about whether diabetes patients who don't use insulin benefit from monitoring their blood sugar
Anticoagulants increase in Xarelto (rivaroxaban) prescriptions
Gout rev up promotion of Uloric for managing gout
Vaccines Prevnar 13 vaccine will be used in certain ADULTS
Compounding new oversight of pharmacy compounding
Practice enjoy the holiday letter from our staff